The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today
European Journal of Nuclear Medicine and Molecular Imaging · 2024
DOI: 10.1007/s00259-023-06552-2 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Daniela-Elena Oprea-Lager und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. d.oprea…. Hauptthemen laut MEDLINE: Nuclear Medicine, Prostatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. d.oprea-lager@amsterdamumc.nl.
- Academic Urology Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
- Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, Groningen, The Netherlands.
- Nuclear Medicine Division, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Policlinico S.Orsola, Bologna, Italy.
Zitieren
APA
Oprea-Lager, D. E., MacLennan, S., Dierckx, R., & Fanti, S. (2024). The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06552-2
Vancouver
Oprea-Lager DE, MacLennan S, Dierckx R, Fanti S. The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today. European Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.1007/s00259-023-06552-2
BibTeX
@article{OpreaLager2024,
author = {Oprea-Lager, Daniela-Elena and MacLennan, Steven and Dierckx, Rudi and Fanti, Stefano},
title = {The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
doi = {10.1007/s00259-023-06552-2}
}
EUVIMED